期刊文献+

混合骨髓移植治疗白血病疗效观察——附4例报告 被引量:1

下载PDF
导出
摘要 目的:探讨降低自体骨髓移植治疗白血病的复发率的方法。方法:用自体骨髓混合半相合异基因骨髓(有核细胞量为6:1)的混合骨髓移植(mixed bone marrow transplantation,MBMT)方法治疗白血病患者4例,观察其重建造血功能情况、近期并发症、远期效果及复发率。结果:3例患者顺利重建造血功能,移植成功。1例发生急性移植物抗宿主病,因败血症于移植后14日死亡。1例移植后发生严重免疫紊乱,于移植后3个月死于肺部感染。1例移植后25个月死于复发。1例已无病存活77个月。结论:混合骨髓移植治疗白血病有一定效果,可降低自体骨髓移植治疗白血病的复发率,加强移植相关并发症的处理有望进一步提高疗效。
出处 《新医学》 北大核心 2006年第5期305-307,共3页 Journal of New Medicine
基金 本课题获广东省重点科技攻关项目资助(编号:97033)
  • 相关文献

参考文献4

二级参考文献12

  • 1[2]Ball ED, Wilson J, Phelps V, et al. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: Results of phase II studies with long-term follow-up [J]. Bone Marrow Transplant, 2000;25(8):823-829.
  • 2[3]Schots R, Van Riet I, Ben Othman T, et al. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia [J]. Bone Marrow Transplant, 2001;28(10):917-922.
  • 3[4]Guglielmi C, Arcese W, Dazzi F, et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose [J]. Blood, 2002;100(2):397-405.
  • 4[5]Marks DI, Lush R, Cavenagh J, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation [J]. Blood, 2002;100(9):3108-3114.
  • 5[7]Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras.I.Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD [J]. J Immunol, 1988;141:2282-2288.
  • 6[10]Sykes M, Harty MW, Szot GL, et al. Interleukin-2 inhibits graft versus host disease promoting activity of CD4+ cells while preserving CD4- and CD8- mediated graft versus leukemia effects [J]. Blood, 1994;83:2560-2569.
  • 7[11]Da WM, Liu Y, Zhong JT et al. Autologous bone marrow transplantation mixed with HLA-haploidentical allogeneic marrow transplantaion for treatment of patients with malignant blood diseases [J]. BMT, 1997;19:107-112.
  • 8[12]Horning SJ, Negrin RS, Hoppe RT, et al. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: Results of a phase II clinical trial [J]. Blood, 2001;97(2):404-409.
  • 9[13]Weisdorf D, Bishop M, Dharan B, et al. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes [J]. Biol Blood Marrow Transplant, 2002;8(4):213-220.
  • 10[14]Yamamoto Y, Wang B, Fukuhara S, et al. Mixed peripheral blood stem cell transplantation for autoimmune disease in BXSB/MpJ mice [J]. Blood, 2002;100(5): 1886-1893.

共引文献7

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部